Michael Marks, Founding Partner for WRVI Capital, Joins the Atonarp Board and Former Berkeley Lights CFO Shaun Holt Joins as Atonarp’s Chief Operating OfficerTOKYO — May 18, 2021 — Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the healthcare, pharma, and semiconductor industries, today announced it has raised a $50 million Series D financing, led by WRVI Capital. The new funding will allow the company to expand its operations to meet growing customer demand in its current markets and expedite the development and commercialization of its molecular diagnostics products. The company has announced the appointment of Shaun Holt as its chief operating officer (COO). “Atonarp is developing the future of point-of-care molecular diagnostics testing,” said Nicholas Brathwaite, founding managing partner of WRVI Capital and Board Chair of Atonarp. “As one of Atonarp’s first investors, we recognized early on that the company’s breakthrough molecular sensor technology could spur innovation across industries. With its seasoned team of technologists, Atonarp will continue to expand its first-in-class, proven, and transformational molecular sensor technology platform to new industries.”